tiprankstipranks
Trending News
More News >
Kainos Laboratories, Inc. (JP:4556)
:4556
Japanese Market
Advertisement

Kainos Laboratories, Inc. (4556) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Kainos Laboratories, Inc. has a market cap or net worth of ¥5.16B. The enterprise value is ―.
Market Cap¥5.16B
Enterprise Value

Share Statistics

Kainos Laboratories, Inc. has 4,558,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,558,860
Owned by Insiders
Owned by Institutions

Financial Efficiency

Kainos Laboratories, Inc.’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.56%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.56%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee39.89M
Profits Per Employee4.82M
Employee Count133
Asset Turnover0.60
Inventory Turnover2.73

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio8.3
PS Ratio0.00
PB Ratio
Price to Fair Value0.78
Price to FCF
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, Kainos Laboratories, Inc. had revenue of 5.31B and earned 641.02M in profits. Earnings per share was 152.06.
Revenue5.31B
Gross Profit2.61B
Operating Income823.60M
Pretax Income827.15M
Net Income641.02M
EBITDA936.87M
Earnings Per Share (EPS)152.06

Cash Flow

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow
Free Cash Flow
Free Cash Flow per Share

Dividends & Yields

Kainos Laboratories, Inc. pays an annual dividend of ¥35, resulting in a dividend yield of 2.56%
Dividend Per Share¥35
Dividend Yield2.56%
Payout Ratio21.18%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.21
52-Week Price Change7.40%
50-Day Moving Average1.24K
200-Day Moving Average1.20K
Relative Strength Index (RSI)56.78
Average Volume (3m)1.26K

Important Dates

Kainos Laboratories, Inc. upcoming earnings date is Oct 28, 2025, TBA (Confirmed).
Last Earnings DateJul 25, 2025
Next Earnings DateOct 28, 2025
Ex-Dividend DateMar 28, 2025

Financial Position

Kainos Laboratories, Inc. as a current ratio of 4.00, with Debt / Equity ratio of ―
Current Ratio4.00
Quick Ratio3.32
Debt to Market Cap0.11
Net Debt to EBITDA-2.95
Interest Coverage Ratio125.34

Taxes

In the past 12 months, Kainos Laboratories, Inc. has paid 186.13M in taxes.
Income Tax186.13M
Effective Tax Rate0.23

Enterprise Valuation

Kainos Laboratories, Inc. EV to EBITDA ratio is 2.68, with an EV/FCF ratio of 3.97.
EV to Sales0.47
EV to EBITDA2.68
EV to Free Cash Flow3.97
EV to Operating Cash Flow3.57

Balance Sheet

Kainos Laboratories, Inc. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities
Total Debt
Net Cash
Net Cash Per Share
Tangible Book Value Per Share¥1.61K

Margins

Gross margin is ―, with operating margin of 15.52%, and net profit margin of 12.08%.
Gross Margin
Operating Margin15.52%
Pretax Margin15.59%
Net Profit Margin12.08%
EBITDA Margin17.66%
EBIT Margin15.71%

Analyst Forecast

The average price target for Kainos Laboratories, Inc. is ¥1,442.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥1,442.00
Price Target Upside15.36% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast4.93%
EPS Growth Forecast-0.26%

Scores

Smart ScoreN/A
AI Score84.4
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis